Immunize tablets: nature’s antibody against cancer

Abstract

Colostrum, also known as first milk, contains therapeutic proteins and peptides that together appear to reverse changes in the signaling of the tumor micro environment that enhance cancer spread. Colostrum, a nutrient-rich fluid produced by female mammals immediately after giving birth, is loaded with immune, growth and tissue repair factors with dozens of biologically active peptides and proteins that affect genes and cell signaling. Several colostrum-derived biologics, such as human α-lactalbuminmade lethal to tumor cells and the human recombinant form of lactoferrin, shows promising results in clinical studies. Lactoferricinpeptide analogs are in early clinical development for cancer immunotherapies. In addition, milk proteins and peptides are well tolerated and many exhibit oral bioavailability, thus they may complement standard therapies to boost overall success incancer treatments.